BRIEF published on 01/15/2026 at 15:44, 15 days 13 hours ago The Vanguard Group Announces Significant Stake in NCC Group plc Form 8.3 The Vanguard Group Takeover Code Securities Disclosure NCC Group Plc
BRIEF published on 01/15/2026 at 15:43, 15 days 13 hours ago The Vanguard Group Discloses Position in Oxford Biomedica Form 8.3 Takeover Code Securities Disclosure Vanguard Group Oxford Biomedica
BRIEF published on 01/15/2026 at 15:43, 15 days 13 hours ago The Vanguard Group Discloses Position in Auction Technology Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Auction Technology
BRIEF published on 01/15/2026 at 15:42, 15 days 13 hours ago The Vanguard Group Discloses Significant Stake in JTC plc Form 8.3 Takeover Code Vanguard Group Shareholding JTC Plc
BRIEF published on 01/15/2026 at 15:42, 15 days 13 hours ago The Vanguard Group Discloses Position in Just Group plc Takeover Code Securities Disclosure Vanguard Group Shareholding Just Group Plc
BRIEF published on 01/15/2026 at 15:41, 15 days 13 hours ago Vanguard Group Reveals Position in Spire Healthcare Group Form 8.3 The Vanguard Group Takeover Code Spire Healthcare Shareholding
BRIEF published on 01/15/2026 at 15:39, 15 days 13 hours ago The Vanguard Group Discloses Stake in Glencore plc Financial Transactions The Vanguard Group Shareholding Takeover Disclosure Glencore Plc
PRESS RELEASE published on 01/15/2026 at 15:39, 15 days 13 hours ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses a 4.69% stake in NCC Group plc through Form 8.3. Details on securities holdings and recent dealings included Form 8.3 Vanguard Group Stake Disclosure Securities Holdings NCC Group Plc
BRIEF published on 01/15/2026 at 15:39, 15 days 13 hours ago The Vanguard Group Discloses Stake in Greencore Group Form 8.3 Takeover Code Vanguard Group Shareholding Greencore Group
PRESS RELEASE published on 01/15/2026 at 15:38, 15 days 13 hours ago Form 8.3 - The Vanguard Group, Inc.: Oxford Biomedica plc The Vanguard Group, Inc. discloses a 1.01% stake in Oxford Biomedica plc in a Form 8.3 filing under Rule 8.3 of the Takeover Code Form 8.3 Rule 8.3 Takeover Code Vanguard Group Oxford Biomedica Plc
Published on 01/31/2026 at 03:15, 2 hours 10 minutes ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 3 hours 5 minutes ago Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 3 hours 45 minutes ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 6 hours 25 minutes ago Avidian Gold Corp. Announces Director Resignation
Published on 01/31/2026 at 02:45, 2 hours 39 minutes ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 7 hours 25 minutes ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 9 hours 14 minutes ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 9 hours 15 minutes ago Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 9 hours 17 minutes ago Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 17:45, 11 hours 40 minutes ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 1 day 11 hours ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 11 hours ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 11 hours ago Cegedim generated LFL revenue growth of 1.1% in 2025
